GGrantIndex
Sort

50,496 grants matching lung cancer

EFRI-BSBA: Photonic Technique for Sensing and Understanding Subcellular Structures at Nanoscale

$2,000,000
Vadim Backman · Northwestern University · · FY2009 · ENG

DCTD Screening Technologies

$2,000,000
Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA

CENTER FOR SINGLE PHOTON-EMITTING CANCER IMAGING AGENTS

$2,000,000
University Of Missouri-Columbia · P50 · FY2004 · CA

CENTER FOR SINGLE PHOTON-EMITTING CANCER IMAGING AGENTS

$2,000,000
University Of Missouri-Columbia · P50 · FY2005 · CA

Comparative Effectiveness in Genomic Medicine

$2,000,000
Katrina Armstrong · University Of Pennsylvania · UC2 · FY2010 · CA

Zero Cryogen Boiloff Technology Magnet: A Regional Animal MRI Resource

$2,000,000
Stefan H Bossmann · University Of Kansas Medical Center · S10 · FY2024 · OD

CENTER FOR SINGLE PHOTON-EMITTING CANCER IMAGING AGENTS

$1,999,999
University Of Missouri-Columbia · P50 · FY2003 · CA

IGF::OT::IGF SBIR Phase II: Topic 338 - Defining Normal Tissue and Tumor Biomarkers of Radiosensitivity to Best Direct Treatment

$1,999,999
David Salzman · Mira Dx, Inc. · N44 · FY2017 · CA

Comparative effectiveness in genomic & personalized medicine for colon cancer

$1,999,998
Katrina A Goddard · Kaiser Foundation Research Institute · RC2 · FY2009 · CA

Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care

$1,999,936
Jane C. Weeks · Dana-Farber Cancer Inst · RC2 · FY2009 · CA

Programs in Clinical Effectiveness of Cancer Pharmacogenomics

$1,999,347
Geoffrey S Ginsburg · Duke University · UC2 · FY2010 · CA

Comparative Effectiveness of Advanced Imaging in Cancer

$1,999,273
Anna N. A. Tosteson · Dartmouth College · RC2 · FY2009 · CA

Nonmyeloablative allogeneic PBSC in globin disorders

$1,999,033
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

SBIR TOPIC 401 PHASE II:

$1,998,128
Ph.d., Peymon Ghazi · Malcova Inc · N44 · FY2023 · CA

Programs in Clinical Effectiveness of Cancer Pharmacogenomics

$1,996,931
Geoffrey S Ginsburg · Duke University · RC2 · FY2009 · CA

The Biology of Lung Metastasis in Breast Cancer

$1,996,618
Jonathan M. Backer · Albert Einstein College Of Medicine · P01 · FY2025 · CA

Detroit Research on Cancer Survivors (Detroit ROCS)

$1,995,543
Ann G Schwartz · Wayne State University · U01 · FY2018 · CA

Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity

$1,995,375
Ignacio E. Sanz · Emory University · U54 · FY2022 · CA

The Epidemiology and Somatic Genomic Pathogenesis of Radon-Related Stroke

$1,995,257
Eric A. Whitsel · Univ Of North Carolina Chapel Hill · R01 · FY2023 · ES

SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES

$1,995,174
Jelena Levi · Cellsight Technologies, Inc. · N44 · FY2022 · CA

Administrative Core A

$1,995,151
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2021 · CA

The HMS Laboratory of Systems Pharmacology

$1,994,178
Peter Karl Sorger · Harvard Medical School · P50 · FY2015 · GM

The Delta Ecology of NSCLC Treatment

$1,992,935
Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA

IBA Cyclone 18/9 Cyclotron

$1,992,300
Stuart S Berr · University Of Virginia · S10 · FY2008 · RR

Modulating Cancer Stem Cell Signaling in Thoracic Malignancies

$1,992,211
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA